Evidence map›Paper›PMID 15544014›Full record

ArticleMayo Clinic proceedings2004

Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome.

Chi-Huei Chiang, Jen-Fu Shih, Wei-Juin Su, Reury-Perng Perng

Open access · bronzeAbstract read
In one paragraph

Article in Mayo Clinic proceedings, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. A comparative overview of COVID-19, MERS and SARS: Review article.International journal of surgery (London, England) · 2020
    Review
  16. Review
  17. Review
  18. Review
  19. Neutralizing antibody response and SARS severity.Emerging infectious diseases · 2005
    Article
  20. The emerging utility of neopterin?Clinical immunology (Orlando, Fla.) · 2005
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chi-Huei ChiangChest Department, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. chiang01@vghtpe.gov.tw
Jen-Fu Shih
Wei-Juin Su
Reury-Perng Perng
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo define the clinical characteristics and clinical course of hospital-acquired severe acute respiratory syndrome (SARS). PATIENTS AND

methodsThis 8-month prospective study of 14 patients with hospital-acquired SARS in Taipei, Taiwan, was conducted from April through December 2003.

resultsThe most common presenting symptoms in our 14 patients with hospital-acquired SARS were fever, dyspnea, dizziness, malaise, diarrhea, dry cough, muscle pain, and chills. Lymphopenia and elevated serum levels of lactate dehydrogenase (LDH) and C-reactive protein (CRP) were the most common Initial laboratory findings. Initial chest radiographs revealed various pattern abnormalities and normal results. Five of the 14 patients required mechanical ventilation. The need for mechanical ventilation was associated with bilateral lung involvement on the initial chest radiograph and higher peak levels of LDH and CRP. Clinical severity of disease varied from mild to severe. At 8 months after disease onset, patients with mild or moderate SARS had normal findings or only focal fibrosis on chest high-resolution computed tomography. However, bilateral fibrotic changes remained in the 4 patients who had recovered from severe SARS, 1 of whom had mild restrictive ventilatory impairment. One patient with severe SARS died; she was elderly and had other comorbidities. Five additional patients had reduced diffusing capacity.

conclusionThe clinical picture of our patients presenting with hospital-acquired SARS revealed atypical pneumonia associated with lymphopenia, elevated serum levels of LDH, rapid clinical deterioration, and lack of response to empirical antibiotic therapy. Substantially elevated levels of LDH and CRP correlated with severe illness requiring mechanical ventilatory support. In those receiving mechanical ventilation, pulmonary function was only mildly reduced at 6 to 8 months after acute illness, consistent with the natural history of acute respiratory distress syndrome due to other causes.

Indexed as

AdultCross InfectionDisease ProgressionFemaleHumansL-Lactate DehydrogenaseLymphopeniaMaleProspective StudiesRadiography, ThoracicRespiratory Function TestsReverse Transcriptase Polymerase Chain ReactionRisk FactorsSevere Acute Respiratory SyndromeStatistics, NonparametricTaiwanL-Lactate Dehydrogenase

Identifiers

PMID15544014
PMCPMC7094584
OpenAlexW2091495292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.